Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11,856.00 GBX | -0.94% | -4.43% | +11.85% |
06:13pm | European Equities Close Lower in Wednesday Trading; EU, Euro Area Inflation Declines in August | MT |
01:43pm | AstraZeneca Says US FDA Approves Fasenra for Rare Vasculitis Treatment | MT |
1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
20 | |||||||||
25 | |||||||||
26 | |||||||||
22 | |||||||||
27 | |||||||||
26 | |||||||||
19 | |||||||||
20 | |||||||||
24 | |||||||||
22 | |||||||||
22 | |||||||||
27 | |||||||||
21 | |||||||||
21 | |||||||||
15 | |||||||||
16 | |||||||||
17 | |||||||||
18 | |||||||||
15 | |||||||||
Average | 21 | ||||||||
Weighted average by Cap. | 23 |
- Stock Market
- Equities
- AZN Stock
- Sector AstraZeneca PLC
- Sector revisions
MarketScreener is also available in this country: United States.
Switch edition